Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Biodesix, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Biodesix held its 2026 annual stockholder meeting on May 19, 2026, where shareholders elected two Class III directors, approved executive compensation on a non-binding basis, and ratified KPMG LLP as the independent auditor for 2026. This is a routine governance event reflecting normal corporate operations and shareholder engagement.
Key Takeaways
Two Class III directors were elected to serve three-year terms through the 2029 annual meeting
Shareholders provided non-binding advisory approval for named executive officer compensation
2 more takeaways